by Alex Kadhim
Researchers from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO) conducted the PHYLOS trial and found that posttransplant cyclophosphamide (PTCy)-based prophylaxis significantly reduces the...
by Alex Kadhim
Researchers from the National Cancer Institute (NCI), USA, have demonstrated that intermediate-dose post-transplantation cyclophosphamide (ID-PTCy) at 25 mg/kg/day administered on days 3 and 4...
by Alex Kadhim
Researchers from Stanford University have demonstrated that administering precision-selected donor regulatory T-cell (Treg) therapy significantly improves graft-versus-host disease-free,...
by Alex Kadhim
Researchers from the University of Minnesota have demonstrated that individualized dosing of rabbit anti-thymocyte globulin (rATG), based on recipient bodyweight and absolute lymphocyte count...
by Alex Kadhim
Researchers from Siriraj Hospital, Mahidol University in Thailand demonstrated that haploidentical hematopoietic stem cell transplantation (haplo-HSCT), combined with post-transplant...
by Alex Kadhim
Researchers from Massachusetts General Hospital and collaborating institutions conducted a prospective, multicenter phase II clinical trial demonstrating that prolonged administration of...